Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

Actions
  • Price (GBX)78.20
  • Today's Change0.10 / 0.13%
  • Shares traded617.02k
  • 1 Year change+2.89%
  • Beta0.5292
Data delayed at least 20 minutes, as of Apr 23 2024 17:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Target Healthcare REIT plc had net income fall from a gain of 49.10m to a loss of 6.57m despite a 6.09% increase in revenues from 63.86m to 67.75m.
Gross margin49.48%
Net profit margin86.12%
Operating margin102.15%
Return on assets6.30%
Return on equity8.91%
Return on investment6.44%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Target Healthcare REIT plc fell by 19.12m. However, the company earned 29.67m from its operations for a Cash Flow Margin of 43.79%. In addition the company used 3.55m on investing activities and also paid 45.23m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.07
Tangible book value per share1.07
More ▼

Balance sheet in GBPView more

Target Healthcare REIT plc has a Debt to Total Capital ratio of 27.31%, a lower figure than the previous year's 36.73%.
Current ratio1.02
Quick ratio--
Total debt/total equity0.3757
Total debt/total capital0.2731
More ▼

Growth rates in GBP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -13.23% and -112.93%, respectively. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)5.37%
Div growth rate (5 year)-5.00%
Payout ratio (TTM)60.10%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
1,647.86
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.